▼ SELL
10b5-1 Plan
$ Value
$202K
Shares
400
Price
$506
Filed
May 5
Insider
Name
Bhatia Sangeeta N.
Title
—
CIK
0001643921
Roles
Director
Transaction Details
Transaction Date
2025-05-02
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
4,831
Footnotes
Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. | Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2024.
Filing Info
Bhatia Sangeeta N.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-08-27 | VRTX | ▼ | $103K |
| 2025-05-02 | VRTX | ▼ | $202K |
| 2025-05-01 | VRTX | A | $0 |
Other Insiders at VRTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SACHS BRUCE I | — | — | 2026-04-15 |
|
WAGNER CHARLES F JR
EVP, CO & FO
|
— | — | 2026-01-22 |
|
LEIDEN JEFFREY M
Executive Chairman
|
— | — | 2026-01-22 |
| Garber Alan M | — | — | 2026-04-15 |
|
Sachdev Amit
EVP Chief Patient & Ext Af Off
|
— | — | 2026-01-22 |
| Upadhyay Suketu | — | — | 2026-04-15 |
|
ALTSHULER DAVID
EVP, Chief Scientific Officer
|
— | — | 2026-01-22 |
|
Kewalramani Reshma
CEO & President
|
— | — | 2026-01-22 |
|
Biller Jonathan
EVP and Chief Legal Officer
|
— | $886K | 2026-02-11 |
|
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
|
— | — | 2026-01-22 |
|
Bozic Carmen
EVP and CMO
|
— | $1.1M | 2026-03-27 |
|
Liu Joy
EVP and Chief Legal Officer
|
— | $439K | 2026-04-01 |
|
Ambrose Kristen
SVP & Chief Accounting Officer
|
— | $634K | 2026-02-11 |
|
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
|
— | $806K | 2026-02-11 |
|
McKechnie Duncan
EVP, Chief Commercial Officer
|
— | — | 2026-01-22 |
|
Bunnage Mark E.
EVP, Chief Scientific Officer
|
— | $931K | 2026-02-11 |